Antimicrobial resistance (AMR) poses a critical threat to global public health and development. In 2019, it directly caused 1.27 million deaths worldwide and contributed to 4.95 million deaths*. Misuse and overuse of antimicrobials in humans, animals, and plants are the primary drivers of drug-resistant pathogens. AMR affects countries of all income levels, with low- and middle-income nations being disproportionately affected due to poverty and inequality.

This resistance jeopardises modern medical advancements, making infections harder to treat and medical procedures riskier. Moreover, there’s an impending crisis in antibiotic development and access, with insufficient research and development efforts to combat rising resistance levels.

Economically, AMR has staggering costs, with estimates suggesting up to US$1 trillion in additional healthcare expenses by 2050 and annual GDP losses of US$1-3.4 trillion by 2030*. Priority strategies to tackle AMR include preventing infections through appropriate antimicrobial use, ensuring universal access to quality diagnosis and treatment, and promoting innovation in surveillance and research for new vaccines, diagnostics, and medicines.

ITN Business will produce a news style programme Defending Our Health: Unravelling Antimicrobial Resistance launching in September 2024. We are partnering with Antibiotic Research UK, the British Society for Antimicrobial Chemotherapy (BSAC) and AMR Industry Alliance to provide editorial interviews and thought leadership in programme. It will also feature an exclusive interview with Professor Dame Sally Davies who is the UK Special Envoy on Antimicrobial Resistance.

    • Presented by journalist and broadcaster, Sharon Thomas, from the ITN London studio, the programme will be hosted on a bespoke page on the ITN Business content hub, as well as being supported by a digital launch, including a paid marketing campaign.

There are commercial opportunities for leading organisations to be featured in the programme and spearhead their own news item. If your organisation wants to share what you stand for and be part of this important conversation about antimicrobial resistance, please contact ITN Business’ Head of Healthcare Programming Georgia Gerstein.

* Source: